Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
Izawa A, Hara Y, Horita N, Muraoka S, Kaneko M, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Tanaka K, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Kobayashi N, Miura K, Nakajima H, Kaneko T. Izawa A, et al. Among authors: nagasawa r. Transl Lung Cancer Res. 2024 Mar 29;13(3):503-511. doi: 10.21037/tlcr-23-855. Epub 2024 Mar 15. Transl Lung Cancer Res. 2024. PMID: 38601457 Free PMC article.
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases.
Tagami Y, Hara Y, Murohashi K, Nagasawa R, Nishikawa Y, Tanaka M, Aoki A, Tanaka K, Nakashima K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Okudela K, Kaneko T. Tagami Y, et al. Among authors: nagasawa r. Can Respir J. 2021 Nov 30;2021:9099802. doi: 10.1155/2021/9099802. eCollection 2021. Can Respir J. 2021. PMID: 34887972 Free PMC article.
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease.
Fujii H, Hara Y, Saigusa Y, Tagami Y, Murohashi K, Nagasawa R, Aoki A, Izawa A, Seki K, Watanabe K, Horita N, Kobayashi N, Kaneko T. Fujii H, et al. Among authors: nagasawa r. Can Respir J. 2023 Feb 8;2023:5088207. doi: 10.1155/2023/5088207. eCollection 2023. Can Respir J. 2023. PMID: 36817552 Free PMC article.
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
Hirata M, Hara Y, Fujii H, Murohashi K, Saigusa Y, Zhao S, Kobayashi M, Nagasawa R, Tagami Y, Izawa A, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T. Hirata M, et al. Among authors: nagasawa r. BMC Pulm Med. 2024 Jan 5;24(1):16. doi: 10.1186/s12890-023-02833-6. BMC Pulm Med. 2024. PMID: 38183005 Free PMC article.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kobayashi N, et al. Among authors: nagasawa r. Thorac Cancer. 2020 Aug;11(8):2125-2129. doi: 10.1111/1759-7714.13503. Epub 2020 Jun 3. Thorac Cancer. 2020. PMID: 32495514 Free PMC article. Clinical Trial.
The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease.
Nishikawa Y, Hara Y, Tagami Y, Nagasawa R, Murohashi K, Aoki A, Tanaka K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T. Nishikawa Y, et al. Among authors: nagasawa r. Can Respir J. 2021 Nov 16;2021:7456315. doi: 10.1155/2021/7456315. eCollection 2021. Can Respir J. 2021. PMID: 34824651 Free PMC article.
88 results